Risedronate and blood alkaline phosphatase increased Patient Reports February 12, 2012

Risedronate Side Effects Report #4614182-X
Risedronate side effect was reported by a Physician from on Mar 04, 2005. Female patient, 88 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: back pain , blood alkaline phosphatase increased, creatine phosphokinase decreased, hyperkalaemia, walking aid user. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with GASMOTIN, STOGAR, APLACE, IFENPRODIL TARTRATE, TEPRENONE, ASPIRIN, PREDNISOLONE. Patient recovered.

Risedronate Side Effects Report #5890688-0
Risedronate side effect was reported by a Consumer or non-health professional from JAPAN on Sept 03, 2008. Female patient, 73 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood urea increased, decreased appetite, gastritis erosive, jaundice , liver disorder. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with ALFAROL, ASPARA, ZOLPIDEM TARTRATE, ETODOLAC, METHYCOBAL, SOLON, CRESTOR, EPADEL. Patient recovered.

Risedronate Side Effects Report #5954623-9
Risedronate side effect was reported by a Physician from JAPAN on Oct 27, 2008. Female patient, 72 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ammonia increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood urea increased, gamma-glutamyltransferase increased, hepatic function abnormal, hypersensitivity. Risedronate dosage: 2.5 MG ONCE DAILY, ORAL. During the same period patient was treated with VOLTAREN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5140802-X
Risedronate side effect was reported by a Physician from JAPAN on Oct 19, 2006. Female patient, 71 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood cholinesterase increased, gamma-glutamyltransferase increased, hepatic function abnormal, jaundice . Risedronate dosage: 2.5 MG, DAILY, ORAL. During the same period patient was treated with PENFILL R. Patient was hospitalized. Patient recovered.


Risedronate Side Effects Report #4750396-6
Risedronate side effect was reported by a Health Professional from JAPAN on Aug 05, 2005. Female patient, 66 years of age, was diagnosed with osteoporosis , pyrexia, cough and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, body temperature increased, c-reactive protein increased, chest x-ray abnormal, cough, cryptogenic organizing pneumonia. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with MEFENAMIC ACID, ASTHMOYLSIN, NIPOLAZIN, PRAVASTATIN, NEUROTROPIN, MENATETRENONE, SAIREI, CINAL. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #4654066-4
Risedronate side effect was reported by a Physician from on Apr 19, 2005. Female patient, 62 years of age, was diagnosed with osteoporosis , nasopharyngitis and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, albumin globulin ratio decreased, aphasia , aspartate aminotransferase increased, blood alkaline phosphatase increased, blood cholesterol increased, blood cholinesterase increased, blood lactate dehydrogenase increased, depressed level of consciousness. Risedronate dosage: 2.5 MG ONCE, ORAL. During the same period patient was treated with LOXONIN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5159320-8
Risedronate side effect was reported by a Physician from JAPAN on Nov 07, 2006. Female patient, 35 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: basophil count decreased, blood alkaline phosphatase increased, blood creatinine decreased, condition aggravated, eosinophil count decreased, granulocytopenia, lymphocyte count increased, monocyte count increased, neutrophil count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with BONALON, FAMOTIDINE, PREDNISOLONE, SULFAMETHOXAZOLE, ALFAROL, PERSANTIN. Patient recovered.

Risedronate Side Effects Report #5126429-4
Risedronate side effect was reported by a Health Professional from UNITED STATES on Sept 25, 2006. Female patient, 52 years of age, weighting 259.0 lb, was diagnosed with osteitis deformans and was treated with Risedronate. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood parathyroid hormone increased, calcium ionised decreased, dysarthria, hungry bone syndrome, hypocalcaemia, mental status changes, myoclonus, procollagen type i c-terminal propeptide increased. Risedronate dosage: 30 MG, DAILY, ORAL. During the same period patient was treated with ALBUTEROL, FUROSEMIDE, AMLODIPINE, IBUPROFEN. Patient was hospitalized. Patient recovered.